AKUMS DRUGS & PHARMACEUTICALS
Back to Income Statement
|
AKUMS DRUGS & PHARMACEUTICALS Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹338 Cr | ₹-4.04 Cr | ₹95 Cr | ₹-253 Cr | ₹123 Cr |
What is the latest Consolidated Net Profit of AKUMS DRUGS & PHARMACEUTICALS ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹338 Cr |
| Mar2024 | ₹-4.04 Cr |
| Mar2023 | ₹95 Cr |
| Mar2022 | ₹-253 Cr |
| Mar2021 | ₹123 Cr |
How is Consolidated Net Profit of AKUMS DRUGS & PHARMACEUTICALS Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹338 Cr | Positive | |
| Mar2024 | ₹-4.04 Cr | Negative | |
| Mar2023 | ₹95 Cr | Positive | |
| Mar2022 | ₹-253 Cr | Negative | |
| Mar2021 | ₹123 Cr | - | |
Compare Consolidated Net Profit of peers of AKUMS DRUGS & PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AKUMS DRUGS & PHARMACEUTICALS | ₹7,030.3 Cr | -0.2% | 4.9% | -27% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,073.0 Cr | -0% | -3.2% | -5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,657.0 Cr | 4% | 5.2% | 11.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,121.0 Cr | 2.4% | 4.5% | 18.3% | Stock Analytics | |
| CIPLA | ₹118,431.0 Cr | -3.5% | -1.5% | -2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,944.0 Cr | -3.2% | -3.3% | -10.6% | Stock Analytics | |
AKUMS DRUGS & PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AKUMS DRUGS & PHARMACEUTICALS | -0.2% |
4.9% |
-27% |
| SENSEX | -2.6% |
-1.3% |
7.2% |
You may also like the below Video Courses